<ARTICLE> 5 <RESTATED> <MULTIPLIER> 1,000 <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> DEC-31-1996 <CASH> 813,678 <SECURITIES> 141,407 <RECEIVABLES> 1,556,990 <ALLOWANCES> 82,351 <INVENTORY> 881,397 <CURRENT-ASSETS> 3,891,285 <PP&E> 7,096,400 <DEPRECIATION> 2,789,429 <TOTAL-ASSETS> 14,307,170 <CURRENT-LIABILITIES> 4,222,193 <BONDS> 2,516,484 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 355,564 <OTHER-SE> 5,744,576 <TOTAL-LIABILITY-AND-EQUITY> 14,307,170 <SALES> 6,974,347 <TOTAL-REVENUES> 7,346,594 <CGS> 1,848,282 <TOTAL-COSTS> 2,118,413 <OTHER-EXPENSES> 3,181,397<F13> <LOSS-PROVISION> 0<F12> <INTEREST-EXPENSE> 288,835 <INCOME-PRETAX> 2,031,290 <INCOME-TAX> 507,821 <INCOME-CONTINUING> 1,523,470 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,523,470 <EPS-PRIMARY> 1.39 <EPS-DILUTED> 1.36 <FN> <F12>-The information called for is not given as the balances are not individually significant. <F13>-Amounts include research and development, selling and general and administrative expenses. </FN>